- Amarillo Biosciences Appoints Dr. Stephen Chen as Chairman and CEO
AMARILLO, Texas, Feb. 22, 2012 /PRNewswire/ -- Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that Dr. Stephen T. Chen has been appointed as Chairman of the Board and Chief Executive Officer. Dr. Joseph Cummins will remain as President and become Chief...
- Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it has reached the target enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide...
- Endo Pharmaceuticals to Present at Cowen & Co. 32nd Annual Health Care Conference
CHADDS FORD, Pa., Feb. 22, 2012 /PRNewswire/ -- Endo Pharmaceuticals Holdings (Nasdaq: ENDP) today announced that Julie McHugh, chief operating officer, will present a corporate overview at the Cowen & Co. 32nd Annual Heath Care Conference on Wednesday, March 7, 2012 at...
- Could You Be Gluten Intolerant? Some May Be Suffering In Silence, Reports Mintel
 CHICAGO, Feb. 22, 2012 /PRNewswire/ -- The gluten-free industry is booming, growing 27% since 2009 and exceeding billion in 2011, and fueled by an abundance of new products in 2010 and 2011 that bear a gluten-free claim. However, despite an increase in popularity and...
- Onyx Pharmaceuticals Reports Full Year and Fourth Quarter 2011 Financial Results
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today reported its financial results for the full year and fourth quarter 2011. Onyx reported non-GAAP net income of .0 million, or
|
The Health Care Blog
|
| The Health Care Blog |
- Live from HIMSS12: ICD-10, Meaningful Use & Social Media
By NEIL VERSEL There has been a lot of buzz around two pieces of news –in one case, lack of news—in the past week. Last Thursday, HHS Secretary Kathleen Sebelius responded to heavy pressure from the American Medical Association and announced a delay to the ICD-10 implementation deadline, currently set for October 2013. Meanwhile, the [...]
- Seizing the Opportunity in the ICD-10 Delay
By HEATHER HAUGEN, PHD Innovative thinkers and influential healthcare leaders aren’t relying on the decisions coming out of HHS to determine their strategy. Despite the fact that many healthcare organizations were on target to transition from ICD-9 to ICD-10, Health and Human Services (HHS) announced it would initiate a process to postpone the date by [...]
- Eric Topol: Too Clever by Three-Quarters
By Matthew Holt Eric Topol was once a lowly (well not that lowly) cardiology professor at the University of Michigan, but he’s now without question the leading renaissance man in health care technology. Virtually every week sees him on some big stage disgnosing his own heart murmur with an iPhone app or showing off how [...]
- The Melody Of Quality Measures: Harmonize And Standardize
By Thomas Tsang, MD and Faraz Ahmad, MD With unsustainably high costs and tremendous gaps in quality and patient safety, the health care system is ripe with opportunities for improvement. For years, many have seen quality measurement as a means to drive needed change. Private and public payers, public health departments, and independent accreditation organizations [...]
- Is North Carolina Medicaid the Healthcare Industry’s Solyndra?
By Al Lewis North Carolina Medicaid recently reported, for the third time, using a third consulting firm, the achievement of massive savings through its patient-centered medical home (PCMH) program, now called Community Care of North Carolina (CCNC). Among other things, CCNC pays the physicians more money in order to encourage and compensate behaviors and processes, [...]
- A New Grassroots Movement By Doctors
By Ron Gutman There’s a new movement in healthcare – and it’s growing from a surprising place. Instead of emerging from government or industry, it’s budding from the grassroots –from everyday physicians. The movement is democratizing health information and giving birth to a new landscape: Interactive Health. Interactive Health is transitioning clinical care from real-world, [...]
- Politics in the Exam Room
By David M Sack MD An ancient maxim of dinner party etiquette, which I believe has been proffered from more than one source, is “never discuss politics, religion or sex in polite company”. In some ways, for me as a physician, entering the exam room with a patient seems to require some similar degree of discretion. But [...]
- Forecast and Ramifications of Payers in the HIE Market
By Naveen Rao The numerous changes in the healthcare sector are forcing stakeholders to develop new business models to prosper, to survive. Among health insurers, this means one thing: diversification. Health reform was the nail in the coffin of yesterday’s business model, a model that had no restrictions on margins, a model where payers sold [...]
- Vegas, Baby, Vegas
It seems that I just got back from Vegas and CES although I had 3 weeks in India & Hong Kong in between. But in a few minutes I’ll be off there again as this time HIMSS brings its modest 40,000 attendees to Vegas. (When I say modest, CES had 200K!) THCB and Health 2.0 [...]
- Dial Back The Hype
By DAVID WHELAN I like health Web sites and tech start-ups. I think the democratization of medical information is a beautiful thing. It’s a cliche that you can find out more about a hotel than a doctor with a few Google searches. I love how that’s starting to change. I also think that electronic medical [...]
|
.66 per diluted share, for the full year 2011...
- Volcano Reports 14 Percent Increase in Fourth Quarter Revenues; Medical Segment Revenues Grow 20 Percent
SAN DIEGO, Feb. 22, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today said revenues in the fourth quarter of...
- Halozyme Therapeutics to Present at the CITI 2012 Global Healthcare Conference
 SAN DIEGO, Feb. 22, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the Citi 2012 Global Healthcare Conference in New York on Wednesday, February 29, 2012 at 11:00 a.m. ET / 8:00 a.m. PT. Kurt Gustafson, Chief Financial Officer, Halozyme Therapeutics,...
- Amerigroup to Present at the Citi 2012 Global Health Care Conference
VIRGINIA BEACH, Va., Feb. 22, 2012 /PRNewswire/ -- Amerigroup Corporation (NYSE: AGP) today announced that it will participate in the Citi 2012 Global Health Care Conference on Feb. 28, 2012, in New York.
A live webcast of the Company's presentation, which begins...
- Questcor Reports Fourth Quarter and Full Year 2011 Financial Results
ANAHEIM, Calif., Feb. 22, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today reported financial results for the fourth quarter and full year ended December 31, 2011.
Net sales for the fourth quarter were .5 million, reflecting continued physician acceptance...
- Express Scripts Reports Fourth Quarter Results
ST. LOUIS, Feb. 22, 2012 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced 2011 fourth quarter and full year net income from continuing operations of 0.4 million and ,275.8 million, or {rss}http://rss.prnewswire.com/industry/health-biotech/{/rss}.59 and http://rss.prnewswire.com/industry/health-biotech/.53 per diluted share, respectively. Adjusted earnings per share, as...
|
User Login (Sign In)
